LBA4Effects of abiraterone acetate plus prednisone/prednisolone in high and low risk metastatic hormone sensitive prostate cancer. (23rd October 2018) - Hoyle, A P; Ali, S A; James, N D; Parker, C C; Cook, A D; Attard, G; Chowdhury, S; Cross, W; Dearnaley, D P; de Bono, J S; Gilson, C E; Gillessen, S; et al.